SCHEMBL1378697

SCHEMBL1378697

CC(C)CCC(=O)Nc1ccc(N2CCCCC2=N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
TP53 P04637 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 9/20 0.41
POLB P06746 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7152058 0.87 NAMPT (0.49) NAMPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL7152000 0.86 SMN1; SMN2 (0.50) NAMPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL1678146 0.84 SMN1; SMN2 (0.54) NAMPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL1677992 0.79 MEN1 (0.60) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL6139947 0.74 RAB9A (0.54) NAMPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL30964182 0.74 ALDH1A1 (0.76) SMN1; SMN2RAB9AALDH1A1GAAL3MBTL1
SCHEMBL6140778 0.73 MAPT (0.64) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL1380603 0.73 F10 (0.59) NAMPTALDH1A1
SCHEMBL7149483 0.73 ALDH1A1 (0.43) NAMPTSMN1; SMN2TP53NPC1RAB9A
SCHEMBL5631461 0.72 F10 (0.61) SMN1; SMN2RAB9AALDH1A1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4732757-B2 2011-07-27 JP claimed
EP-1490056-A1 N-'4-(2-IMINO-PYRROLIDIN-1-YL)PHENYL)-ACETAMIDE AND CORRESPONDING PIPERIDINE DERIVATIVES AS FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GmbH (DE) 2004-12-29 EP claimed
WO-2003084533-A1 N-`4-(2-IMINO-PYRROLIDIN-1-YL)PHENYL!-ACETAMIDE AND CORRESPONDING PIPERIDINE DERIVATIVES AS FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2003-10-16 WO claimed